Continuing Multiple Sclerosis Education To Be Offered at AIMS Live Meetings
With multiple sclerosis (MS) prevalence rates still at concerning levels of 90 for every 100,000 Americans, researchers are continuously seeking to learn more about the disease, and are aggressively working to develop novel treatments and interventions for symptom management. This poses an ongoing challenge for healthcare professionals and academics, as it may be difficult for them to remain up to speed on the latest research updates and medical best practices for treating MS. Thanks to three multinational organizations’ efforts, however, more medical professionals and educators will be able to implement and help disseminate the latest updates on Multiple Sclerosis.
The France Foundation, The Consortium of Multiple Sclerosis Centers (CMSC)m and Nurse Practitioner Alternatives (NPA) have teamed up to launch a comprehensive program of study to educate healthcare providers on MS updates. Advances in Multiple Sclerosis (AIMS) provides free continuing education credits through either live or on-demand opportunities.
One of AIMS’ upcoming live learning meetings is scheduled Saturday, October 11, at the Marriott World Center in Orlando, FL. A second AIMS live meeting will take place on Saturday, November 22 at the Omni New Haven Hotel in New Haven, CT, which will feature opening remarks from David A. Hafler, MD, and Gilbert H. Glaser, a Professor of Neurology and Immunobiology, and Chairman of the Department of Neurology at Yale School of Medicine. All of the meetings sessions are free, and will include the following topics:
- Updates on Developments in Multiple Sclerosis: Immunopathology and MRI
- Updates on the Current and Emerging Treatments for Multiple Sclerosis
- Comprehensive Care in MS: Improving Communication and Coordination Among the Multidisciplinary Team
During these live meetings, attendees will also have engaging, open forums with invited experts on MS, such as:
- Joseph R. Berger, MD (Chair), Professor of Neurology and Chief of the MS Division, Perelman School of Medicine, University of Pennsylvania
- Guy J. Buckle, MD, Director of Neuroimaging Research, Shepherd Center
- Marie Namey, RN, MSN, MSCN Clinical Nurse Specialist, Mellen Center for MS Treatment & Research, The Cleveland Clinic
While these meetings are complementary, AIMS encourages attendees to register at http://www.cmeaims.com/live-mtgs.php.
To those interested in accessing the organization’s other free educational services, such as webinars, podcasts, references, etc., visit http://www.cmeaims.org. For specialized resource materials for professionals and researchers, visit http://www.cmscscholar.org.
One of the more intriguing clinical updates that the MS community may soon learn about via a continuing education effort such as AIMS is a dendtritic cell vaccine against MS. Scientists from the Baylor Institute for Immunology Research are currently studying the possibility of an MS treatment that will not only help fight off the disease, but preserve the immune system as well.